Related Experiment Videos
[Vesical sphincter disorders in Parkinson disease]
1Service de Rééducation, Centre Hospitalier, Gonesse, Courbevoie.
Revue Neurologique
|January 1, 1993
Summary
Parkinson's disease frequently causes urinary bladder disorders. Dopamine depletion likely causes bladder hyperreflexia in Parkinson's patients, improving with apomorphine.
Area of Science:
- Neurology
- Urology
Background:
- Urinary bladder disorders are common in Parkinson's disease (PD).
- Early assessment of urinary symptoms is crucial for treatment decisions, particularly before prostate surgery.
- Understanding the pathophysiology of bladder dysfunction in PD is essential for patient care.
Observation:
- This study examined 41 patients with Parkinson's disease.
- Bladder hyperreflexia was observed in 88% of patients, while 12% exhibited bladder hyporeflexia.
- Apomorphine administration improved bladder activity in hyperreflexic patients but not in hyporeflexic ones.
Findings:
- The high prevalence of bladder hyperreflexia in PD suggests a link to nigrostriatal dopamine depletion.
- Apomorphine's efficacy in improving hyperreflexia supports the role of dopamine deficiency.
- The underlying mechanisms of bladder hyporeflexia in Parkinson's disease remain less understood.
Implications:
- These findings highlight the importance of evaluating bladder function in Parkinson's patients.
- Dopamine modulation may be a therapeutic target for urinary disorders in PD.
- Further research is needed to elucidate the pathophysiology of bladder hyporeflexia in Parkinson's disease.